I think ASX shares are a great way to grow your wealth over the long-term. You just need to choose the right ideas which have long-term growth potential.

What about ASX blue chips?

If you’re thinking about investing in shares like Commonwealth Bank of Australia (ASX: CBA) and BHP Group Ltd (ASX: BHP) then I think you may as well go for an ultra-low-cost exchange-traded fund (ETF) like BetaShares Australia 200 ETF (ASX: A200) which has an annual management fee of just 0.07% per annum.

But I think these four ASX shares could beat the market over the shorter-term and longer-term:

Share 1: MFF Capital Investments Ltd (ASX: MFF)

MFF Capital is a leading listed investment company (LIC). MFF Capital aims to invest in overseas shares rather than ASX shares. 

There are few Australian investors with the investment track record of Chris Mackay. He manages MFF Capital and has achieved very strong returns over the past five years with top share picks like Visa and Mastercard. These two businesses still make up more than a third of the portfolio. There is a long-term shift away from cash payments and towards contactless payments and eCommerce. 

The LIC currently has a large pile of cash that it wants to deploy when the right investing opportunities come along. At the end of June 2020 it had 44% of its assets as net cash. I think that provides a solid base for downside protection this year as well as optionality to buy shares at beaten down prices.

At the current MFF Capital share price it’s trading at a 4% discount to the pre-tax net tangible assets (NTA) per share.

Share 2: Bubs Australia Ltd (ASX: BUB)

Bubs is an infant formula company. It specialises in goat milk products, but it also sells grass-fed organic cow milk infant formula too. It sells baby food too.

The company is on a very good course at the moment, it’s delivering strong growth. In the FY20 half-year result it reported revenue growth of 37% to $28.8 million. In the FY20 third quarter, infant formula revenue and China revenue both increased by more than 100%.

The ASX share’s gross margin continues to improve as well. I think Bubs can become a much larger business over the next few years, investors just need to be patient as it delivers on its growth potential.

At the current Bubs share price, I’d be happy to buy some shares for the long-term.

Share 3: Vitalharvest Freehold Trust (ASX: VTH)

Vitalharvest is an agricultural real estate investment trust (REIT) which owns some of the largest citrus and berry properties in Australia which are leased to Costa Group Holdings Ltd (ASX: CGC).

In the FY20 interim result the REIT reported it had a net asset value (NAV) of $0.95 per unit. At the current Vitalharvest share price it’s trading at a 16% discount to that NAV, assuming the NAV hasn’t changed since December 2019.

I’m also excited for two other reasons. First, the ASX share has a new manager that will expand the REIT’s acquisition hunting ground to include other areas of the food supply chain with properties related to the processing, storage and logistics of food.

The other reason why I’m excited is due to a potential return to good results for Costa. Vitalharvest has a profit-share agreement with Costa. A return to normal profits for Costa could give Vitalharvest a boost.

At the current Vitalharvest it’s trading with a distribution yield of 5.9%.

Share 4: Brickworks Limited (ASX: BKW)

Brickworks is one of Australia’s largest building product businesses. It sells a variety of products like bricks, precast and roofing. COVID-19 could cause a material hit to the construction industry over the next 12 months. But that’s why the Brickworks share price is down by 18% over the past six months. A downturn is a good time to buy a cyclical business like a building product ASX share in my opinion.

However, I’m particularly excited by the recent Amazon news. Brickworks owns 50% of an industrial property trust along with Goodman Group (ASX: GMG). Brickworks recently announced that the property trust had succeeded in getting Amazon to commit to building a massive distribution warehouse at its Oakdale site in Sydney. That is in addition to the big distribution warehouse that Coles Group Limited (ASX: COL) is planning to build.

I think Brickworks could actually be a fairly defensive investment. At the current share price, Brickworks offers a grossed-up dividend yield of 5%.

Foolish takeaway

I think each of these ASX shares are good value and could deliver market-beating returns over the next 12 months and the long-term. I think Bubs and MFF Capital could deliver the strongest returns over the next few years due to the focus on growth, though Vitalharvest and Brickworks look good value to me.

More reading

• My ASX share of the week
• 4 ASX shares I’d buy to protect against a recession
• How to create a yearly income of $65,000 in dividends
• 2 easy ASX shares for beginners
• Top ASX dividend shares to buy in July 2020

Motley Fool contributor Tristan Harrison owns shares of Magellan Flagship Fund Ltd. The Motley Fool Australia owns shares of and has recommended Brickworks, BUBS AUST FPO, and COSTA GRP FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 4 ASX shares I’d buy with $4,000 appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/39jzlYf

The Tesserent Ltd (ASX: TNT) share price gained 28% today, while also smashing its 52-week high in the process. The Tesserent share price was sent flying on the news the company has achieved its financial objectives for the year and also secured a debt facility.

What does Tesserent do?

Tesserent provides internet security to a wide range of Australian and international customers, via services such as perimeter protection, internal monitoring and alerts, secure internet connectivity and co-location. Its customers include education providers, corporate enterprises, and government organisations.

The company’s flagship Cyber 360 strategy delivers a comprehensive security service including identification, protection and 24/7 monitoring against cyber security threats. According to Tesserent, it is Australia’s largest listed dedicated cyber security company.

Trading update

The Tesserent share price skyrocketed today following news the company had achieved its previously announced FY20 financial objectives and locked in an additional $10 million in funding. 

A key highlight for the company is the fact its $40 million revenue run rate was achieved. Furthermore, Tesserent announced that it is likely to become earnings before interest, tax, depreciation and amortisation (EBITDA) and cash flow positive in June. These metrics are subject to audit, with the company providing a comprehensive business update and quarterly update later this month.

Tesserent has also managed to secure an additional $10 million debt facility. The agreement was with Tesserent’s existing debt provider, Pure Asset Management. The funds will be drawn as required to support acquisitions by the company.

Chair of Tesserent Geoff Lord commented:

[W]e’re extremely pleased to be working with PURE Asset Management who continue to support the firm’s vision and strategy. This new facility provides the funding cornerstone to continue to drive the Company’s acquisition strategy with minimal dilutionary impact on our existing shareholders.

About the Tesserent share price

The Tesserent share price has surged higher so far this year, gaining upwards of 150%. Tesserent shares have been pushed higher following the successful acquisitions of Pure Security, Rivium and North in the past year.

Cyber security is a hot topic following the recent cyber attacks on the government, with the news that cyber security is getting a $1.35 billion spending boost no doubt adding to the Tesserent share price’s impressive run.

More reading

• Where to invest $5,000 into ASX shares right now
• 4 ASX shares I’d buy with $4,000
• Market close: ASX 200 falls 0.5%
• ASX investors were buying these 5 international shares last week
• Top fund manager names favourite ASX growth shares

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Tesserent share price leaps 28% following trading update appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2Wya6ME

The S&P/ASX 200 Index (ASX: XJO) dropped around 0.5% today, falling back to 6,002 points.

Victoria reported another 275 new COVID-19 cases today and NSW clusters continue to grow in number.

Here are some of the highlights from the ASX today:

Eclipx Group Ltd (ASX: ECX) share price jumps

The Eclipx share price has jumped 8.5% today after announcing an asset sale. The company has sold Right2Drive for up to $26.5 million in fixed and contingent consideration.

The fixed consideration of $19.2 million includes $15 million payable at transaction completion and $4.2 million to be paid 18 months later. The contingent consideration of up to $7.3 million will be payable at six-month intervals following completion for a period of up to 24 months, based on pre-agreed collection rates on the current debtor book.

The book value of Right2Drive was $28 million at 31 March 2020. Therefore, the company will recognise a loss on the sale.

The transaction includes an ongoing commercial relationship with Right2Drive, including a right to supply new vehicle leases to Right2Drive for a period of three years.

All net proceeds will be used to reduce debt of the ex ASX 200 share.

Sydney Airport Holdings Pty Ltd (ASX: SYD) June 2020 traffic performance

Sydney Airport announced its June 2020 traffic numbers today.

The numbers were still down heavily. International passengers were down 97.6% to 32,000 and domestic passengers dropped 93.3% to 140,000.

While domestic passengers have materially increased in June compared to April and May, Sydney Airport expects to continue to see significant reductions in passenger traffic for as long as domestic and international travel restrictions persist.

As you’d expect, the ASX 200 share saw a large reduction in volume in all major nationality passenger groups. China, New Zealand, India, UK, USA and Japan passenger numbers were all down more than 90%.

The Sydney Airport share price fell 1.3% today.

Catapult Group International Ltd (ASX: CAT) share price surges 11.4%

Sports analytics business Catapult gave investors a preview into its FY20 numbers today.

The company said that it achieved free cashflow for FY20 of $9 million after taking a conservative approach with cost control measures. It also managed its working capital. Catapult achieved positive free cashflow a year earlier than expected. 

Total revenue for FY20 is expected to be between $100 million and $101 million. Earnings before interest, tax, depreciation and amortisation (EBITDA) is expected to be between $11.5 million and $12.5 million.

Around 75% of the company’s revenue is subscription based, which has helped the company through the COVID-19 shutdowns despite many professional sporting leagues pausing their competitions.

The company warned that a significant proportion of sales that would otherwise have been made in the fourth quarter of FY20 are now expected to be made in the first half of FY21.

Record June quarter and annual inflows in FY20 for Hub24 Ltd (ASX: HUB)

The fintech platform business announced that its funds under administration (FUA) was $17.2 billion at 30 June 2020, a 34% increase compared to last year.

Hub24 achieved record annual net inflows of $4.95 billion in FY20, up from 27% from FY19. The quarter net inflows for June 2020 was $1.1 billion, up 11% on the prior corresponding period.

Over the fourth quarter of FY20 FUA increased by $2.1 billion, including the positive market movement of $1 billion.

Hub24 said it maintained second place in both adviser satisfaction and adviser advocacy in the recent ‘investment trends’ report. Its Hub24 platform market share has increased to 1.94%.

The company said its new business pipeline continues to grow with 34 new licensee agreements signed during the quarter and 110 new advisers using the platform.

Hub24 managing director Andrew Alcock said: “We remain committed to delivering the highest levels of service to support advisers and their clients as they seek to meet their objectives. We would like to thank our customers and our staff for their continued support during this challenging environment.”

The Hub24 share price dropped 0.2% today. 

More reading

• Where to invest $5,000 into ASX shares right now
• Why the BlueScope share price is outperforming today
• Are you a ‘risky’ investor in ASX 200 shares?
• One thing you should be doing ahead of the ASX reporting season
• 3 top Warren Buffett quotes for ASX investors this week

Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Catapult Group International Ltd and Hub24 Ltd. The Motley Fool Australia has recommended Catapult Group International Ltd and Hub24 Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Market close: ASX 200 falls 0.5% appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2ZHelYm

I always find it interesting and useful to see where our fellow ASX investors are spending their capital, both domestically and with international shares. Luckily, Commonwealth Bank of Australia (ASX: CBA)’s CommSec brokering platform gives us a list of its most traded shares each week. As the largest broker in Australia, it’s a set of statistics that has some weight. So let’s look at some of the companies listed beyond our shores that were the most popular last week (13–17 July).

Which international shares are ASX investors buying?

1) Tesla Inc. (NASDAQ: TSLA)

Last week’s winner by a mile was Elon Musk’s electric vehicle and battery company Tesla. Tesla has been setting chins a-wagging in recent weeks as its share price has ballooned. One year ago, Tesla shares were going for around US$255. Today, those same shares will set you back around US$1,500, which includes a 50% jump in just the last month. Appreciation like this always attracts a lot of attention, so there’s no surprise Tesla takes out the top spot.

2) Nio Inc. (NYSE: NIO)

Number 2 this week is another electric car company in the form of Nio. Nio is often called the ‘Tesla of China’ despite it being nowhere near the scale of its rival Tesla just yet. Nio shares have become a speculative plaything in recent months. Back in May, Nio shares were going around US$3.30. But the last 2 weeks have seen Nio surge to over US$16 and then back down to the US$11 we see today. If you want to get your kicks on the Route 66 of investing, it seems you might have needed to take an electric car for the trip last week.

3) Microsoft Corporation (NASDAQ: MSFT)

Now we’re getting into some blue-chip territory. Microsoft is one of the largest companies in the world and dominates the world of personal computers with its Windows operating system and Microsoft Office suite of productivity apps. Its business has largely been unaffected by the coronavirus pandemic and possibly explains why ASX investors were clambering over the company’s shares last week.

4) Apple Inc. (NASDAQ: AAPL)

Apple really needs no introduction. Along with Microsoft, it’s one of the largest companies on the planet right now and is known for its ubiquitous iPhone product. In addition, every other product line that Apple offers is successful in its own right, whether that be the Mac, iPad, AirPods or its subscription services like Apple Music. Apple is unquestionably a fantastic company and would make a great investment (in my view) for any Aussie investor.

5) Amazon.com Inc. (NASDAQ: AMZN)

Last but certainly not least is Jeff Bezos’ Amazon. Along with Apple and Microsoft, Amazon is another member of the trillion-dollar company club in terms of market capitalisation. Despite its sheer size, Amazon shares have been on an absolute tear in recent weeks, climbing from around US$2,000 a share in early April to more than US$3,000 a share earlier this month. Everyone knows Amazon is one of the most disruptive and dominant companies in the world, and unrivalled in the world of e-commerce. As such, Aussie investors don’t seem to want to let the high price tag of Amazon today get in the way of them owning a piece of the action.

Foolish takeaway

Whilst we have many great companies on the ASX, it’s always interesting to see what Aussie investors are finding attractive beyond our shores as well. It’s never been easier to buy international shares, so if you aren’t already, it might be a lucrative exercise to check out some of these names and see how they could fit in your own portfolio.

More reading

• Why CBA and Macquarie shares could be in the buy zone
• ASX 200 Weekly Wrap: Blue chip shares pull ASX 200 back over 6,000 points
• 2 high yield ASX dividend shares I would buy
• Are our ASX bank shares expensive by global standards?
• Fund managers have been buying these ASX shares

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. Sebastian Bowen owns shares of Tesla. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Amazon, Apple, Microsoft, and Tesla and recommends the following options: long January 2021 $85 calls on Microsoft, short January 2021 $115 calls on Microsoft, short January 2022 $1940 calls on Amazon, and long January 2022 $1920 calls on Amazon. The Motley Fool Australia has recommended Amazon and Apple. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post ASX investors were buying these 5 international shares last week appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2CUNqiw

From time to time, we Fools like to look at some of the more successful fund managers on the ASX, and have a cheeky look at where they are finding good places to put their money. So today, we’re checking out Hyperion Asset Management – a growth-focused fund manager that has delivered top returns for its investors over the past few years.

In fact, according to reporting in the Australian Financial Review (AFR), Hyperion’s Global Growth Companies Fund topped the ASX’s managed funds in terms of 5-year performance, with an average annual return of 18.3% for the 5 years to 30 April. With numbers like those, I think this fund manager is well worth listening to.

So what exactly is Hyperion investing in right now?

A top ASX fundie’s share picks

According to the AFR, Hyperion has 2 managed funds: its global growth fund, and the Australian Growth Companies Fund.

For the global growth fund, the top holdings are as follows:

• Amazon.com Inc.
• Microsoft Corporation
• Tesla Inc.
• Alphabet Inc.
• PayPal Holdings

There are some of the most well-known global growth names right there, to be sure. It’s clear Hyperion is focusing on the big tech names for the lion’s share of its portfolio. And for good reason too! All 5 of these companies are pushing on record-high share prices right now. Tesla, in particular, has appreciated close to 200% in the past 6 months alone.

According to Hyperion fund managers Jason Orthman and Mark Arnold, the company isn’t worried about stretched valuations either:

We think they’re better value now than they were in January… They’re highly innovative. There’s a lot of optionality embedded in those businesses, and a lot of smart people are incentivised to create better features for existing products and expand product ranges. We are pretty comfortable that the value is there and the returns should be there over the next five to 10 years.

But let’s also look at Hyperion’s locally focused Australian growth fund as well. Here are this fund’s top holdings, according to the AFR:

• CSL Limited (ASX: CSL)
• Xero Limited (ASX: XRO)
• Domino’s Pizza Enterprises Ltd (ASX: DMP)
• Macquarie Group Ltd (ASX: MQG)
• Afterpay Ltd (ASX: APT)

That’s a far more balanced portfolio than the global growth fund. We have healthcare darling CSL, tech-savvy Xero, payments heavyweight Afterpay and fast food king Dominos. Even a bank (Macquarie) is in the list.

Mr Arnold also stated that he sees a growing divide about where he wants Hyperion’s funds to be, and where he doesn’t:

It really reinforces our view that we are permanently stuck in a no-growth or low-growth world. We think that’s going to be a big drag on earnings per share growth for the major indices around the world for the next 10 years… You’ve really got to back the winners. If you’re on the other side of the divide, you’re really going to struggle.

Foolish takeaway

I think Hyperion’s insights are very much worth taking on board, especially considering its enviable track record. I especially like the fact that the fund is taking a holistic view of the markets and where they see the future taking them. It’s an approach I think is worth implementing in our own growth portfolios as we navigate these uncertain times.

More reading

• Why the BlueScope share price is outperforming today
• Is the Zip share price a buy after falling 20% last week?
• Zip and Openpay were among the most traded shares on the ASX last week
• 5 of the worst performing ASX shares from last week
• Why these 9 ASX shares have doubled in value in the past year

Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Sebastian Bowen owns shares of Alphabet (A shares) and Tesla. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Alphabet (A shares) and Tesla. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and Xero. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended Alphabet (A shares) and Domino’s Pizza Enterprises Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Top fund manager names favourite ASX growth shares appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3jozn5F

The BlueScope Steel Limited (ASX: BSL) is among the best performing stocks today even as the market quickly lost steam to close in the red.

Shares in the steel building products maker jumped 3% to $11.58 ahead of the market close to become the fourth best performer on the S&P/ASX 200 Index (Index:^AXJO).

The only stocks to beat BlueScope are the Resolute Mining Limited (ASX: RSG) share price, the Afterpay Ltd (ASX: APT) share price and the NRW Holdings Limited (ASX: NWH) share price. Even then, these ASX stocks aren’t ahead by much more.

In contrast, the top 200 stock benchmark fell 0.4% after briefly making gains in early trade on Monday.

Better than expected earnings

The surge in interest in BlueScope comes after brokers passed judgement on the stock following the company’s trading update on Friday.

The analysts at Macquarie Group Ltd (ASX: MQG) lifted its price target on the stock to $12.55 from $12.20 and reiterated its “outperform” recommendation on the stock.

The broker noted that the update was better than expected and believes Australian housing demand will remain resilient.

Upside risk from US steel spreads

Credit Suisse echoed a similar optimism when it repeated its “outperform” rating on the stock. The broker pointed out that BlueScope’s second half earnings before interest and tax (EBIT) of $260 million was 40% above consensus forecasts and a 27% beat on its estimates.

It also believes that US steel spreads are unsustainably low and any recovery on that front in FY21 presents upside risk to its $12.80 price target on the stock.

“We view BSL as a high quality cyclical exposure,” said Credit Suisse. “Its trading performance in what has been a very challenged period for markets in 2H20, particularly in the US, further endorses that quality view.”

It also helps that BlueScope holds net cash of $100 million on its balance sheet as that will help it see through the uncertain COVID-19 recovery.

Another target price upgrade

Meanwhile, UBS also upped its price target on BlueScope by 30 cents to $11.80 a share as its second half EBIT was $100 million above what it was expecting.

The beat is largely driven by BlueScope’s Building Products Asia & North America division, which benefitted from a better than expected recovery in China and improved margins in North America.

However, with the BlueScope share price trading close to the broker’s price target, UBS kept its “neutral” recommendation on the stock.

More reading

• Are you a ‘risky’ investor in ASX 200 shares?
• Is the Zip share price a buy after falling 20% last week?
• One thing you should be doing ahead of the ASX reporting season
• 3 top Warren Buffett quotes for ASX investors this week
• Zip and Openpay were among the most traded shares on the ASX last week

Motley Fool contributor Brendon Lau owns shares of BlueScope Steel Limited and Macquarie Group Limited. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool Australia owns shares of AFTERPAY T FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Why the BlueScope share price is outperforming today appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2CwXfDw

ASX 200 share investors have been betting big in recent months. That’s the message that’s coming out of new academic research according to an article in the Australian Financial Review (AFR).

The AFR has seen an unpublished research paper suggesting retail investors were “aggressive purchasers of high risk highly leveraged stocks”.

Investors also reportedly piled into “large market capitalisation stocks” and “stocks exhibiting large price declines prior to the lockdown”.

The new research findings come after ASIC reported an increase in retail trading between 24 February and 3 April. A lot of first-time investors have been buying and selling ASX 200 shares, but how have their investments performed?

Are you a risky ASX 200 share investor?

According to the AFR, the paper suggests that “retail investors have fundamentally altered their participation in the stock market during the COVID-19 lockdown period.”

So, what constitutes a “high risk highly leveraged stock”?

I think there are a few ASX 200 shares that spring to mind. They’re more likely to be concentrated in the hardest-hit industries amid the coronavirus pandemic. A few of those sectors include travel, hospitality and energy.

We’ve seen Virgin Australia hit troubled waters in 2020 and default on its debt. There’s also other big names like Sydney Airport Holdings Pty Ltd (ASX: SYD) and Santos Ltd (ASX: STO), which have significant debt balances.

To be clear, that’s not always a bad thing. In fact, the use of leverage can often be a good thing for ASX 200 share returns.

However, in times like these, cash is king. Less debt means fewer obligations to meet covenants and make lenders happy.

It’s OK to buy “high risk highly leveraged stocks” – as long as you’re aware of the risk. These ASX 200 shares have often dropped for a reason, as institutional investors sell down their positions.

Will retail investors outperform?

The answer so far appears to be yes. The S&P/ASX 200 Index (ASX: XJO) has rocketed 32% higher since 23 March.

That means many of these retail investors, including first-timers, have been on a hot streak.

However, it’s worth remembering that investing in ASX 200 shares is a long-term game. Short-term trading is fraught with danger, let alone the taxes and transaction fees that need to be paid on entry and exit.

That could be a warning sign that the smart (and big) money in town is betting against your average Joe in the market.

In fact, the AFR article reported that retail investors were net buyers of $3.5 billion in assets, while institutional investors were net sellers of $3.2 billion.

More reading

• Why the BlueScope share price is outperforming today
• One thing you should be doing ahead of the ASX reporting season
• 3 top Warren Buffett quotes for ASX investors this week
• 5 top performing ASX 200 shares from last week
• Why CSR, South32, Sydney Airport, & Webjet shares are tumbling lower

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Are you a ‘risky’ investor in ASX 200 shares? appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2ZM4j8p

The Redbubble Ltd (ASX: RBL) share price has continued its remarkable run on Monday.

The ecommerce company’s shares jumped a further 9.5% to reach a record high of $2.30.

When the Redbubble share price reached that level, it meant they were up an astonishing 475% from their March low.

Why is the Redbubble share price at a record high?

Investors have been fighting to get hold of Redbubble’s shares over the last few months after it followed the lead of Kogan.com Ltd (ASX: KGN) and Temple & Webster Group Ltd (ASX: TPW) by reporting exceptionally strong sales growth during the pandemic.

For example, last month the company released an update which revealed that fourth quarter to date, marketplace revenue was up 107% over the prior corresponding period.

This meant that year to date, marketplace revenue was up 42% on the prior corresponding period. This compares to growth of 26% for the first half and 25% for the third quarter.

Another positive was that its operating expenses had only lifted 7.7% during April and May, in comparison to the first two months of the third quarter.

As a result, its operating earnings before interest, tax, depreciation and amortisation (EBITDA) for the period 1 July 2019 to 31 May 2020 was $11.9 million. This compares to the operating EBITDA of $3.8 million it achieved in FY 2019.

What is driving this growth?

This strong growth has been driven by the acceleration in online activity throughout the fourth quarter of FY 2020 because of the pandemic.

Management notes that it has experienced an increase in demand at both of its marketplaces, Redbubble and TeePublic, as well as across core geographies and product categories.

Pleasingly, despite the rapid increase in sales, its supply chain has managed to cope and customer orders have been fulfilled within expectations.

Is it too late to invest?

While I have no doubts that Redbubble will continue to benefit from the shift to online shopping, I think its shares are fully valued now.

In light of this, I wouldn’t be in a rush to invest just yet and would suggest investors wait for a better entry point in the future.

More reading

• 2 ASX tech shares with stellar growth prospects
• Leading brokers name 3 ASX shares to buy right now
• The latest ASX shares to be upgraded by top brokers to “buy”
• Why AMP, IOOF, Redbubble, & Westpac shares are charging higher
• ASX retailers beware! Amazon.com is gearing up for its next major attack

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd and Temple & Webster Group Ltd. The Motley Fool Australia has recommended Kogan.com ltd, REDBUBBLE FPO, and Temple & Webster Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post The Redbubble share price is up almost 500% from its low: Is it too late to invest? appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2WzErKE

The Immuron Limited (ASX: IMC) share price is up by 6.86% on news that the U.S. Food and Drug administration (FDA) has provided guidance in relation to the clinical development pathway for its new oral therapeutics.

The oral therapeutics are being developed to treat campylobacteriosis and E. coli (ETEC) infections. The Immuron share price was trading over 11% higher following the release, before retreating to its current level of 24 cents per share.

What does Immuron do?

Immuron is an Australian biopharmaceutical company that focuses on developing and commercialising orally delivered antibodies, used in the treatment of inflammatory and infectious diseases.

Immuron has a novel and safe technology platform with one current drug generating revenue, Trevelan. Trevelan reduces the risk of traveller’s diarrhea and minor gastro-intestinal disorders, and is antimicrobial. It is licensed in Australia, Canada and sold as a dietary supplement in the US.

What caused the Immuron share price to jump?

The Immuron share price jumped after the company released news it had received written guidance for its new investigational drug. The FDA review provided a written response to the non-clinical questions posed in its briefing documentation submitted in early June. The FDA also provided additional guidance and comments to support the new drug submission.

There are set to be two human phase II clinical trials for the company’s oral therapeutics, to be conducted in 2021. One trial will focus on the ability of the hyperimmune product to protect volunteers against campylobacteriosis. The other trial will focus on ETEC infections.

Immuron CEO Dr. Jerry Kanellos commented: “This is an important milestone in the development of any new drug for therapeutic evaluation. The information obtained from this review will assist in the development of the IND application and provides a clear roadmap forward for conducting the two planned clinical studies next year.”

What now for Immuron?

The Immuron share price has seen a stark reversal in fortunes this year, jumping 275% on 9 June in response to news of the briefing documentation mentioned above being submitted to the FDA.

While this is good news, Immuron’s drug is still in its very early days and will need a lot of stones to fall into place for it to hit the market. In saying this, the FDA guidance is a huge step forward, hence today’s movement in the Immuron share price.

More reading

• Why the BlueScope share price is outperforming today
• Are you a ‘risky’ investor in ASX 200 shares?
• The Redbubble share price is up almost 500% from its low: Is it too late to invest?
• Is the Zip share price a buy after falling 20% last week?
• Buy and hold these mid cap ASX shares for strong potential returns

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Immuron share price shoots 6% higher after receiving FDA guidance for new drug appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3jpz6jc